Biologics
Hospira Launches Biologics 'Clock' and Web Resource to Raise Awareness of Potential Biogenerics' Impact
Published in Drug Law Weekly, May 19th, 2009
Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, today launched a clock tracking real-time U.S. prescription sales of costly biologic drugs as part of an informational Web resource highlighting the potential impact of biogenerics - generic versions of biologics - on the U.S. healthcare system. Although biogenerics are widely available in Europe and other parts of the world today, there is currently no legislative pathway allowing the U.S. Food and Drug Administration (FDA) to approve these safe, cost-effective alternatives for Americans.
"As the first U.S. company to launch a biogeneric medicine in Europe, Hospira brings unique...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2009-05-19)
More Articles from Drug Law Weekly
- Acorda Therapeutics, Inc.
Acorda Therapeutics Announces FDA Acceptance of Fampridine-SR New Drug Application for Filing - Adverse Drug Reactions
Study data from University of Texas provide new insights into adverse drug reactions - Behavior
Research from University of California yields new findings on behavior - Campaign for Tobacco-Free Kids
Campaign for Tobacco-Free Kids Honors Chairman Henry Waxman for Leadership in Reducing Tobacco's Devastating Toll - Center for Women in Law
Top Women Lawyers Call for President Obama to Select Woman to Supreme Court - Clinical Trial Research
Abbey Spanier Rodd & Abrams, LLP, Announces Class Action Lawsuit on Behalf of Sequenom, Incorporated Shareholders - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
